Liver News and Research

RSS

Exercise can be used as a treatment for nonalcoholic fatty liver disease

The 150 minutes of moderate to intense aerobic activity per week that is recommended by the U.S. Department of Health and Human Services can significantly reduce liver fat, according to new research by Penn State College of Medicine researchers.

9 Feb 2023

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Penn State College of Medicine researchers confirmed exercise can lead to meaningful reductions in liver fat for patients with nonalcoholic fatty liver disease.

8 Feb 2023

Patient's satisfaction with physician associated with completion of bariatric surgery

Patients' satisfaction with their physicians may influence their decisions to undergo bariatric surgery, according to a multicenter study involving UT Southwestern and the UTHealth School of Public Health published in JAMA Network Open.

8 Feb 2023

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Researchers discussed studies that explored T-cell immunity induced by SARS-CoV-2 infection and COVID-19 vaccination in cancer patients, individuals with HIV, and recipients of solid organ transplants.

8 Feb 2023

Researchers highlight the dysregulation of hepatokines in people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases.

7 Feb 2023

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

In a recent study published in The New England Journal of Medicine, researchers reviewed selected acute-phase proteins concerning their production, structure, and function.

7 Feb 2023

People who regularly drink coffee have significantly lower blood pressure

Drinking coffee helps maintain low blood pressure. People who drink two or three cups of coffee a day have lower blood pressure than those who drink just one cup or none at all.

7 Feb 2023

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows.

7 Feb 2023

Metabolically unhealthy people may be at increased risk of obesity-related cancer

For up to 40 years, nearly 800,000 people from Sweden, Norway and Austria have been tracked based on how their BMI and metabolic health - that is, their blood pressure, blood glucose levels and blood fats - affect the risk of suffering from obesity-related cancers.

7 Feb 2023

Liver surgery may be safer in high-volume hospitals

A new paper in the British Journal of Surgery, published by Oxford University Press, finds that patients undergoing liver surgery fare better in higher-volume hospitals; their mortality rates are lower.

7 Feb 2023

Decisions by CVS and Optum panicked thousands of their sickest patients

The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.

7 Feb 2023

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the publication of a peer-reviewed study in the Journal of Clinical and Translational Hepatology, “Breath Biopsy to identify exhaled volatile organic compounds as biomarkers for liver cirrhosis detection”.

From Owlstone Medical Ltd 7 Feb 2023

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma.

6 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

A new paper in the Journal of Clinical Investigation describes drugs that could help lose weight and manage type 2 diabetes mellitus (T2DM).

6 Feb 2023

Penn scientists discover a cellular pathway that keeps Ebola virus from exiting human cells

In their evolutionary battle for survival, viruses have developed strategies to spark and perpetuate infection. Once inside a host cell, the Ebola virus, for example, hijacks molecular pathways to replicate itself and eventually make its way back out of the cell into the bloodstream, where it can spread further.

3 Feb 2023

Liver News and Research

Exercise can be used as a treatment for nonalcoholic fatty liver disease

Exercise can lead to meaningful reductions in liver fat for patients with NAFLD, research confirms

Patient's satisfaction with physician associated with completion of bariatric surgery

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Researchers highlight the dysregulation of hepatokines in people with NAFLD

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

People who regularly drink coffee have significantly lower blood pressure

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Metabolically unhealthy people may be at increased risk of obesity-related cancer

Liver surgery may be safer in high-volume hospitals

Decisions by CVS and Optum panicked thousands of their sickest patients

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

Gut hormone receptor polyagonists show promise for obesity and diabetes

Penn scientists discover a cellular pathway that keeps Ebola virus from exiting human cells

Study reveals a vulnerability of macrophages that contributes to chronic inflammatory diseases

Study identifies a drug candidate for the treatment of fatty liver disease

Research reveals a candidate drug and biomarker to target uveal melanoma

The safety and tolerability of Remdesivir in children affected by COVID-19

Knowing your cholesterol level can be a crucial factor in overall health

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News